Condition: Breast Cancer · Radiation · Breast Reconstruction · Sponsor: Tianjin Medical University Cancer Institute and Hospital
This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
This description comes directly from the study's public registry record.
Jian Yin · +86-22-23340123 · yinjian@tjmuch.com
Bowen Ding · +86-22-23340123 · ding_x87@126.com
Always discuss trial participation with your own doctor first.
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Gansu Provincial Cancer Hospital | Lanzhou, Gansu, China | Recruiting |
| Jilin Cancer Hospital | Ch’ang-ch’un, Jilin, China | Recruiting |
| Tianjin Medical University Cancer Institute and Hospital | Tianjin, Tianjin Municipality, China | Recruiting |
| Zhejiang Provincial People's Hospital | Hangzhou, Zhejiang, China | Recruiting |
| Technical University of Munich | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04967976